Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Comparative study of the prognostic value of survival prognostic scoring systems in patients with essential thrombocythemia: IPSET, MIPSS-ET, AAA, and AAA].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 Jun 2026

Zhao S Y, Xu Z F, Qin T J, Li B, Qu S Q, Sun Q, Jia Y J, Li C W, Pan L J, Gao Q Y, Jiao M, Bao Z F, Xiao Z J

Abstract excerpt

Objective: To validate and compare the applicability of the international prognostic score for ET (IPSET), the mutation-enhanced international prognostic systems for ET (MIPSS-ET), triple A (AAA), and triple A plus (AAA+) survival prognostic scoring systems in Chinese patients with essential thrombocythemia (ET) . Methods: In this external validation and comparative study of clinical prediction models, 423...

Read the complete abstract on PubMed

Topics

Humans
Thrombocythemia, Essential
Prognosis
Retrospective Studies
Mutation
Female

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Middle Aged

Male

Source

Open in PubMed Open full text

Identifiers

PMID: 42706155
DOI: 10.3760/cma.j.cn121090-20260131-00072
PMCID: PMC13575519

Genes

CALR
MPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Comparative study of the prognostic value of survival prognostic scoring systems in patients with essential thrombocythemia: IPSET, MIPSS-ET, AAA, and AAA].PMID 42706155Read ↗

Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.Semantic proximity Read ↗

A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.Semantic proximity Read ↗

The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.Semantic proximity Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China.Semantic proximity Read ↗

Development and validation of a multiple factor-based prognostic score system of thrombosis in polycythemia vera (MFPS-PV)Semantic proximity Read ↗

Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.Semantic proximity Read ↗

Essential Thrombocythemia: One-Center Data in a Changing Disease.Semantic proximity Read ↗

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.Semantic proximity Read ↗

Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia.Semantic proximity Read ↗

Prognostic risk model for patients with high-risk polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.